Detalhe da pesquisa
1.
Comparison of Fixed-Dose Inhaled Epoprostenol and Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome in Critically Ill Adults.
J Intensive Care Med
; 36(4): 466-476, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32133901
2.
BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
Circulation
; 139(19): 2238-2255, 2019 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30759996
3.
Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill.
Ann Pharmacother
; 54(2): 105-112, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31544470
4.
Pulmonary Hypertension: The Role of Lung Transplantation.
Heart Fail Clin
; 14(3): 327-331, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29966630
5.
Pulmonary Hypertension Related to Chronic Obstructive Pulmonary Disease and Diffuse Parenchymal Lung Disease: A Focus on Right Ventricular (Dys)Function.
Heart Fail Clin
; 14(3): 403-411, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29966637
6.
The Right Heart International Network (RIGHT-NET): Rationale, Objectives, Methodology, and Clinical Implications.
Heart Fail Clin
; 14(3): 443-465, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29966641
7.
An official European Respiratory Society statement: pulmonary haemodynamics during exercise.
Eur Respir J
; 50(5)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29167297
8.
Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.
Transpl Int
; 30(1): 41-48, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27678492
9.
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.
Eur Respir J
; 58(4)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210790
10.
Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.
Thorax
; 69(2): 123-9, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24431095
11.
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
Arthritis Rheum
; 65(12): 3194-201, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24022584
12.
Exercise-induced pulmonary hypertension: physiological basis and methodological concerns.
Am J Respir Crit Care Med
; 187(6): 576-83, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23348976
13.
[New trial designs and potential therapies for pulmonary artery hypertension]. / Pulmoner arter hipertansiyonunda yeni çalisma tasarimlari ve potansiyel tedaviler.
Turk Kardiyol Dern Ars
; 42 Suppl 1: 106-18, 2014 Oct.
Artigo
em Turco
| MEDLINE | ID: mdl-25697038
14.
Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot study.
Arthritis Rheum
; 64(12): 4072-7, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22777623
15.
Pulmonary hypertension complicating connective tissue disease.
Semin Respir Crit Care Med
; 34(5): 581-99, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24037627
16.
Pulmonary hypertension complicating interstitial lung disease and COPD.
Semin Respir Crit Care Med
; 34(5): 600-19, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24037628
17.
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial.
BMJ Open Respir Res
; 10(1)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460276
18.
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.
Ann Rheum Dis
; 71(8): 1335-42, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22307943
19.
Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.
Arthritis Rheum
; 63(10): 3078-85, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21618205
20.
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease.
Arthritis Rheum
; 63(11): 3540-6, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21769849